Amazon is moving into the pharmacy business by launching its own online pharmacy and prescription delivery services, the company recently announced.
The first offering, Amazon Pharmacy, allows...
FDA recently proposed updates to its regulations to clarify the types of evidence the agency considers when determining the “intended use” of FDA-regulated products.
The proposed...
Although prices for migraine medications rose by 40 percent through 2017, they sharply declined at the beginning of 2018 and haven’t seen much of an increase since, according to a GoodRx report....
A recent study found that switching from brand name to generic cholesterol medications has saved Medicare billions of dollars between 2014 and 2018, even as the number people on cholesterol-lowering...
The Justice Department announced that pharmaceutical company Novartis agreed to pay $642 million in two separate settlements to resolve healthcare fraud allegations involving False Claims Act (FCA)...
Pharmaceutical companies significantly increased drug costs for 245 drugs between January 20 and June 20, with more than 75 percent of the drugs impacted directly pertaining to COVID-19, according to a...
Department of Justice (DOJ) recently charged Glenmark Pharmaceuticals Inc. for the it role in antitrust violations from May 2013 to December 2015.
The DOJ’s complaint alleged that the...
A coalition of 51 attorney generals from around the US recently filed an antitrust complaint alleging that over two dozen drug manufacturers inflated the price of generic drugs illegally.
The...
Medicaid spent an estimated $761 million in excess costs over seven years due to delayed generic drug entry costs, according to a recent study.
Delayed generic drug entry is common,...
A recent analysis of a randomized clinical trial found that the antidepressant bupropion was not superior to a placebo for the treatment of apathy in patients with dementia of Alzheimer type (DAT)...
The Department of Justice will soon decide whether to charge Teva Pharmaceuticals for an alleged healthcare fraud scheme to fix prices of certain generic medicines. But the company isn’t...
HHS recently announced that it will expand pharmaceutical manufacturing in the US to produce medicines needed during the COVID-19 pandemic and boost capacity for producing finished generic drugs.
For...
The Department of Justice announced that Apotex Corp, a generic pharmaceutical company, agreed to pay a $24.1 million criminal penalty for the role it played in antitrust violations from May 2013 to...
Long-term buprenorphine treatment was linked to significantly lower rates of prescription opioid use and opioid-related events, including medically treated overdoses, according to a study from Columbia...
Two-thirds of US adults reported that prescription drug prices have increased either “a little” or “a lot” since 2017, the first year of the Trump administration, according to a...
Novartis recently announced its commitment to donate up to 130 million doses of generic hydroxychloroquine, a potential COVID-19 treatment.
For more coronavirus updates, visit our resource...
Pharmacy benefit manager (PBM) reimbursement for generic drugs significantly varies by medication and plan, and does not respond to price hikes, according to a study from 3 Axis Advisors.
Researchers...
FDA recently announced it has requested that manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately.
Last year, FDA became aware of independent...
Patients will now have access to a cheaper version of the drug at the center of a recent price gouging case. In an announcement on Feb. 28, the FDA reported that it has approved the first generic drug...
The Department of Justice recently announced that it has charged generic pharmaceutical company Sandoz Inc. for fixing generic drug prices, rigging bids, and other antitrust...
